Jacob T. Maddux

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Adherence to Asthma Biologics”.

Adherence to Asthma Biologics

CHEST Journal(2020)10.1016/j.chest.2020.10.050

N/A

0DataRank · unranked

38 citations

Jonathan Inselman, Molly M. Jeffery, Regina W. Lam, Nilay D. Shah, Matthew A. Rank +1 more

Asthma Patients Who Stop Asthma Biologics Have a Similar Risk of Asthma Exacerbations as Those Who Continue Asthma Biologics

The Journal of Allergy and Clinical Immunology In Practice(2021)10.1016/j.jaip.2021.02.031

N/A

0DataRank · unranked

36 citations

Jonathan Inselman, Jacob T. Maddux, Regina W. Lam, Nilay D. Shah, Matthew A. Rank +1 more

National decline in asthma exacerbations in United States during coronavirus disease 2019 pandemic

Annals of Allergy Asthma & Immunology(2021)10.1016/j.anai.2021.09.017

N/A

0DataRank · unranked

11 citations

Jonathan Inselman, Molly M. Jeffery, Jacob T. Maddux, Matthew A. Rank, Regina W. Lam

Persistence of asthma biologic use in a US claims database

Annals of Allergy Asthma & Immunology(2021)10.1016/j.anai.2021.04.026

N/A

0DataRank · unranked

5 citations

Jonathan Inselman, Molly M. Jeffery, Regina W. Lam, Nilay D. Shah, Matthew A. Rank +1 more

A prediction model for asthma exacerbations after stopping asthma biologics

Annals of Allergy Asthma & Immunology(2022)10.1016/j.anai.2022.11.025

N/A

0DataRank · unranked

16 citations

Molly M. Jeffery, Jacob T. Maddux, Regina W. Lam, Nilay D. Shah, Matthew A. Rank +2 more